Synaptosomes Still Viable after 25 Years of Superfusion

Neurochemical Research

Volumn 25, Issue 9-10, 2000, Pages 1265-1274

  Raiteri, Luca ^a,b,c   Raiteri, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UGO BASILE   (Italy)

^c STOELTING Co   (United States)

Author keywords

Neurotransmitters; Superfusion technique; Synaptosomes

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ANIMAL; ENDOCYTOSIS; EXOCYTOSIS; INSTRUMENTATION; METABOLISM; METHODOLOGY; PERFUSION; PHYSIOLOGY; REVIEW; SYNAPSE; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

ANIMALS; ENDOCYTOSIS; EXOCYTOSIS; NEUROTRANSMITTER AGENTS; PERFUSION; SYNAPSES; SYNAPTIC TRANSMISSION; SYNAPTOSOMES;

EID: 0034302965     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007648229795     Document Type: Article

References (95)

1. Raiteri, M., Angelini, F., and Levi, G. 1974. A simple apparatus for studying the release of neurotransmitter from synaptosomes. Eur. J. Pharmacol. 25:411-414.
2. Levi, G. and Raiteri, M. 1974. Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptake. Nature 250:735-737.
3. Levi, G. and Raiteri, M. 1978. Modulation of γ-aminobutyric acid transport in nerve endings: role of extracellular γ-aminobutyric acid and of cationic fluxes. Proc. Natl. Acad. Sci. USA 75: 2981-2985.
4. Levi, G., Poce, U., and Raiteri, M. 1976. Uptake and exchange of GABA and glutamate in isolated nerve endings. Pages 273-289, in Levi, G., Battistin, L., and Lajtha, A. (eds.), Transport Phenomena in the Nervous System, Plenum Press, New York.
5. 3H]norepinephrine induced by various agents in hypothalamic synaptosomes. Mol. Pharmacol. 13:746-758.
6. Raiteri, M., Cerrito, F., Cervoni, A. M., and Levi, G. 1979. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208:195-202.
7. Maura, G., Gemignani, A., Versace, P., Martire, M., and Raiteri, M. 1982. Carrier-mediated and carrier-independent release of serotonin from isolated central nerve endings. Neurochem. Int. 4:219-224.
8. Levi, G., Patrizio, M., and Gallo, V. 1991. Release of endogenous and newly synthesized glutamate and of other amino acids induced by non-N-methyl-D-aspartate receptor activation in cerebellar granule cell cultures. J. Neurochem. 56:199-206.
9. 2+-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J. Pharmacol. Exp. Ther. 256:1132-1138.
10. Phillis, J. W., Walter, G. A., and Simpson, R. E. 1991. Brain adenosine and transmitter amino acid release from the ischemic rat cerebral cortex: effects of the adenosine deaminase inhibitor deoxycoformycin. J. Neurochem. 56:644-650.
11. 2+-independent release of glutamate during in vitro anoxia in isolated nerve terminals. J. Neurochem. 57:1159-1164.
12. 3H]serotonin. NaunynSchmiedeb. Arch. Pharmacol. 345:1-6.
13. Gobbi, M., Parazzoli, A., and Mennini, T. 1998. In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool. Naunyn-Schmiedeb. Arch. Pharmacol. 358:323-327.
14. Rudnick, G. and Wall, S. C. 1992. The molecular mechanism of ecstasy [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA 89:1817-1821.
15. Courtney, M. J., Enkvist, M. O. K., and Åkerman, K. E. O. 1995. The calcium response to the excitotoxin kainate is amplified by subsequent reduction of extracellular sodium. Neuroscience 68:1051-1057.
16. 3H]-norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic GMP. J. Pharmacol. Exp. Ther. 275:14-22.
17. Pifl, C., Drobny, H., Reither, H., Hornykiewicz, O., and Singer, E. A. 1995. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Mol. Pharmacol. 47:368-373.
18. Sulzer, D., Chen, T.-K., Lau, Y. Y., Kristensen, H., Rayport, S., and Ewing, A. 1995. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15:4102-4108.
19. Gudelsky, G. A. and Nash, J. F. 1996. Carrier-mediated release of serotonin by MDMA: implications for serotonin - dopamine interactions. J. Neurochem. 66:243-249.
20. 3H]S-HT from rat hippocampal slices. Neuropharmacology 35: 1769-1777.
21. 3H]D-aspartate from primary astrocyte cultures in response to raised external potassium. J. Neurosci. 16:7803-7811.
22. Zuiderwijk, M., Veenstra, E., Lopes da Silva, F. H., and Ghijsen, W. E. J. M. 1996. Effects of uptake carrier blockers SK&F89976A and L-Trans-PDC on in vivo release of amino acids in rat hippocampus. Eur. J. Pharmacol. 307:275-282.
23. 2+-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Br. J. Pharmacol. 121:1735-1743.
24. Silvia, C. P., Jaber, M., King, G. G., Ellinwood, E. H., and Caron, M. G. 1997. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience 76:737-747.
25. Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., and Amara, S. G. 1997. Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17:960-974.
26. Hanania, T. and Johnson, K. M. 1998. Regulation of neurotransmitter release by endogenous nitric oxide in striatal slices. Eur. J. Pharmacol. 359:111-117.
27. Jones, S. R., Gainetdinov, R. R., Wightman, R. M., and Caron, M. G. 1998. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18:1979-1986.
28. Obrenovitch, T. P., Zilkha, E., and Urenjak, J. 1998. Effects of pharmacological inhibition of glutamate-uptake on ischaemiainduced glutamate efflux and anoxic depolarization latency. Naunyn-Schmiedeb. Arch. Pharmacol. 357:225-231.
29. 3H]y-aminobutyric acid in rat hippocampal synaptosomes. Mol. Brain Res. 55:337-340.
30. Soghomonian, J.-J. and Martin, D. L. 1998. Two isoforms of glutamate decarboxylase: Why? Trends Pharmacol. Sci. 19:500-505.
31. 14C-GABA release from rat brain synaptosomes. Neuroscience 85:989-997.
32. Kimelberg, H., Seki, Y., Tranmer, B., Keller, R., and Feustel, P. 1999. Marked reduction of ischemia-induced EAA release by an inhibitor of the GLT-1 transporter and an anion channel antagonist. J. Neurochem. 72(suppl.):S34A.
33. Koch, H. P., Chamberlin, A. R., and Bridges, R. J. 1999. Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult. Mol. Pharmacol. 55:1044-1048.
34. +. Neuroscience 93:285-292.
35. 2+-independent release of neurotransmitters. J. Neurochem. 58:395-405.
36. Bernath, S. 1992. Calcium-independent release of amino acid neurotransmitters: fact or artifact? Prog. Neurobiol. 38:57-91.
37. Attwell, D., Barbour, B., and Szatkowski, M. 1993. Nonvesicular release of neurotransmitter. Neuron 11:401-407.
38. Levi, G. and Raiteri, M. 1993. Carrier-mediated release of neurotransmitters. Trends Neurosci. 16:415-419.
39. Heron, A., Springhetti, V., Seylaz, J., and Lasbennes, F. 1995. Effects of a glutamate uptake inhibitor on glutamate release induced by veratridine and ischemia. Neurochem. Int. 26:593-599.
40. Longuemare, M. C. and Swanson, R. A. 1997. Net glutamate release from astrocytes is not induced by extracellular potassium concentrations attainable in brain. J. Neurochem. 69: 879-882.
41. Levy, L. M., Warr, O., and Attwell, D. 1998. Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake. J. Neurosci. 18:9620-9628.
42. Pisani, A., Calabresi, P., Tozzi, A., Bernardi, G., and Knopfel, T. 1998. Early sodium elevations induced by combined oxygen and glucose deprivation in pyramidal cortical neurons. Eur. J. Neurosci. 10:3572-3574.
43. Langer, S. Z. 1981. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32:337-362.
44. Langer, S. Z. 1997. 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol. Sci. 18:95-99.
45. Starke, K. 1981. Presynaptic receptors. Annu. Rev. Pharmacol. Toxicol. 21:7-30.
46. Chesselet, M. F. 1984. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience 12: 347-375.
47. Raiteri, M., Marchi, M., and Maura, G. 1984. Release of catecholamines, serotonin and acetylcholine from isolated brain tissue. Pages 431-462, in Lajtha, A. (ed.) Handbook of Neurochemistry, vol. 6, Plenum Publishing Co., New York.
48. Illes, P. 1989. Modulation of transmitter and hormone release by multiple neuronal opioid receptors. Rev. Physiol. Biochem. Pharmacol. 112:139-233.
49. Starke, K., Göthert, M., and Kilbinger, H. 1989. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol. Rev. 69:864-989.
50. B receptors. Trends Pharmacol. Sci. 14:259-261.
51. Mulder, A. H. and Schoffelmeer, A. N. M. 1993. Multiple opioid receptors and presynaptic modulation of neurotransmitter release in the brain. Pages 125-144, in Herz, A. (ed.), Handbook of Experimental Pharmacology, Springer Verlag, Berlin.
52. Ruzicka, B. B. and Jhamandas, K. H. 1993. Excitatory amino acid action on the release of brain neurotransmitters and neuromodulators: biochemical studies. Prog. Neurobiol. 40:223-247.
53. McGehee, D. S. and Role, L. W. 1996. Presynaptic ionotropic receptors. Curr. Opin. Neurobiol. 6:342-349.
54. Wu, L.-G. and Saggau, P. 1997. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci. 20:204-212.
55. Malva, J. O., Carvalho, A. P., and Carvalho, C. M. 1998. Kainate receptors in hippocampal CA3 subregion: evidence for a role in regulating neurotransmitter release. Neurochem. Int. 32:1-6.
56. Miller, R. J. 1998. Presynaptic receptors. Annu. Rev. Pharmacol. Toxicol. 38:201-227.
57. Ribeiro, J. A. 1999. Adenosine A2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Eur. J. Pharmacol. 375:101-113.
58. 4 muscarinic receptors. J. Pharmacol. Exp. Ther. 266:142-146.
59. 3H]dopamine release. Br. J. Pharmacol. 117:595-606.
60. Pittaluga, A., Bonfanti, A., and Raiteri, M. 1997. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn-Schmiedeb. Arch. Pharmacol. 356:29-38.
61. 1D receptors sited on different neurons and involved in different functions. Br. J. Pharmacol. 126:607-612.
62. A receptor subtypes in adult rat hippocampus and cerebellum. Neuroscience 73:697-704.
63. Pittaluga, A. and Raiteri, M. 1990. Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur. J. Pharmacol. 191:231-234.
64. Pittaluga, A. and Raiteri, M. 1992. N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization J. Pharmacol. Exp. Ther. 260:232-237.
65. Fink, K., Bonisch, H., and Göthert, M. 1990. Presynaptic NMDA receptors stimulate noradrenaline release in the rat cerebral cortex. Eur. J. Pharmacol. 185:115-117.
66. Desce, J. M., Godeheu, G., Galli, T., Artaud, F., Chéramy, A., and Glowinski, J. 1992. L-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience 47: 333-339.
67. Pittaluga, A. and Raiteri, M. 1994. HIV-1 envelope protein gp120 potentiates NMDA-evoked noradrenaline release by a direct action at rat hippocampal and cortical noradrenergic nerve endings Eur. J. Neurosci. 6:1743-1749.
68. Pittaluga, A., Pattarini, R., Severi, P., and Raiteri, M. 1996. Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS 10:463-468.
69. Pattarini, R., Pittaluga, A., and Raiteri, M. 1998. The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus. Neuroscience 8:147-157.
70. Paudice, P., Gemignani, A., and Raiteri, M. 1998. Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist. Eur. J. Neuroscience 10:2934-2944.
71. A receptors mediating glutamate release in an alcohol-sensitive rat line. Neuropharmacology 38:1273-1279.
72. A receptor subtypes in the rat brain. Naunyn-Schmiedeb. Arch. Pharmacol. 357:401-407.
73. A receptor function in rat hippocampus and cerebellum. Neurochem. Int. 34: 399-405.
74. Bonanno, G. and Raiteri, M. 1994. Release-regulating presynaptic heterocarriers. Prog. Neurobiol. 44:451-462.
75. Bonanno, G. and Raiteri, M. 1992. Are neurotransmitter carriers cell-specific markers? Trends Neurosci. 15:482.
76. Raiteri, M., Bonanno, G., and Pende, M. 1992. GABA and glycine modulate each other's release through heterocarriers sited on the releasing axon terminals of rat central nervous system. J. Neurochem. 59:1481-1489.
77. Jonas, P., Bischofberger, J., and Sandkuhler, J. 1998. Corelease of two fast neurotransmitters at a central synapse. Science 281:419-424.
78. Raiteri, M., Garrone, B., and Pittaluga, A. 1992. N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal J. Pharmacol. Exp. Ther. 260:238-242.
79. 5 receptors mediating activation of phosphoinositide metabolism. Br. J. Pharmacol. 121:91-96.
80. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 356:521-523.
81. Seeman, P. and Van Tol, H. H. M. 1994. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:264-270.
82. Sokoloff, P. and Schwartz, J.-C. 1995. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:270-275.
83. L'hirondel, M., Chéramy, A., Godeheu, G., Artaud, F., Saiardi, A., Borrelli, E., and Glowinski, J. 1998. Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res. 792: 253-262.
84. Lu, Y., Grady, S., Marks, M. J., Picciotto, M., Changeux, J.-P., and Collins, A. C. 1998. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287:648-657.
85. Lonart, G., Janz, R., Johnson, K. M., and Südhof, T. C. 1998. Mechanism of action of rab3A in mossy fiber LTP. Neuron 21:1141-1150.
86. Ashton, A. C. and Dolly, J. O. 1991. Microtubule-dissociating drugs and A23187 reveal differences in the inhibition of synaptosomal transmitter release by botulinum neurotoxins types A and B. J. Neurochem. 56:827-835.
87. Link, E., Edelmann, L., Chou, J. H., Binz, T., Yamasaki, S., Eisel, U., Baumert, M., Südhof, T. C., Niemann, H., and Jahn, R. 1992. Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis. Biochem. Biophys. Res. Comm. 189:1017-1023.
88. McMahon, H. T., Foran, P., Dolly, J. O., Verhage, M., Wiegant, V. M., and Nicholls, D. G. 1992. Tetanus toxin and botulinum type A and B inhibit glutamate, γ-aminobutyric acid, aspartate, and metenkephalin release from synaptosomes. J. Biol. Chem. 267:21338-21343.
89. Blasi, J., Binz, T., Yamasaki, S., Link, E., Niemann, H., and Jahn, R. 1994. Inhibition of neurotransmitter release by clostridial neurotoxins correlates with specific proteolysis of synaptosomal proteins. J. Physiol. (Paris) 88:235-241.
90. Fassio, A., Sala, R., Bonanno, G., Marchi, M., and Raiteri, M. 1999. Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F. Neuroscience 90:893-902.
91. Stecher, B., Hens, J. J., Weller, U., Gratzl, M., Gispen, W. H., and De Graan, P. N. 1992. Noradrenaline release from permeabilized synaptosomes is inhibited by the light chain of tetanus toxin. FEBS Lett. 312:192-194.
92. Nichols, R. A., Sihra, T. S., Czernik, A. J., Nairn, A. C., and Greengard, P. 1990. Calcium/calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes. Nature 343:647-651.
93. 2+-induced noradrenaline release, B-50 phosphorylation and dephosphorylation, and calmodulin binding. J. Neurochem. 64: 1127-1136.
94. Åkerman, K. E. O. and Heinonen, E. 1983. Qualitative measurements of cytosolic calcium ion concentration within isolated guinea pig nerve endings using entrapped arsenazo III. Biochim. Biophys. Acta 732:117-121.
95. Raiteri, M., Sala, R., Fassio, A., Rossetto, O., and Bonanno, G. 2000. Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms. J. Neurochem. 74:423-431.